Human umbilical cord mesenchymal stem cells regulate immunoglobulin a secretion and remodel the diversification of intestinal microbiota to improve colitis
BackgroundMesenchymal stem cell (MSC) therapy has emerged as a promising novel therapeutic strategy for managing inflammatory bowel disease (IBD) mainly via dampening inflammation, regulating immune disorders, and promoting mucosal tissue repair. However, in the process, the associated changes in th...
Main Authors: | Airu Liu, Xing Wang, Xiaonan Liang, Wenxin Wang, Chenyang Li, Jiaming Qian, Xiaolan Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2022.960208/full |
Similar Items
-
Intravenous immunoglobulin in the treatment of severe Clostridium difficile colitis
by: Nihar Shah, et al.
Published: (2014-01-01) -
Human umbilical cord mesenchymal stem cells ameliorate colon inflammation via modulation of gut microbiota-SCFAs-immune axis
by: Airu Liu, et al.
Published: (2023-09-01) -
Evaluation of intestinal microbiota, short-chain fatty acids, and immunoglobulin a in diversion colitis
by: Kentaro Tominaga, et al.
Published: (2021-03-01) -
Clinical and Pathologic Remission of Pediatric Ulcerative Colitis with Serum-Derived Bovine Immunoglobulin Added to the Standard Treatment Regimen
by: Rachelle A. Soriano, et al.
Published: (2017-05-01) -
Pyoderma gangrenosum associated with ulcerative colitis and tuberculosis brain abscess successfully treated with intravenous immunoglobulin
by: G S Nayanathara, et al.
Published: (2024-01-01)